Attached files

file filename
EX-10.1 - GRANT NOTICE FOR STOCK AWARD ISSUED JULY 24, 2015 - Rafina Innovations Inc.ex101.htm



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): July 24, 2015
 
HCi Viocare
Exact name of registrant as specified in its charter

Nevada
000-53089
30-0428006
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

 
Kintyre House, 209 Govan Road, Glasgow, Scotland
 
G51 1 HJ
(Address of principal executive offices)
(Zip Code)

+44 141 3700321
Registrant’s telephone number, including area code
 
 
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
1

 


SECTION 3  SECURITIES AND TRADING MARKETS

ITEM 3.02  UNREGISTERED SALES OF EQUITY SECURITIES

On July 24, 2015, the Company approved the issuance of 50,000 common shares for the services provided by Ms. Vasiliki Bountri, employee, in the form of stock awards which shall vest in accordance with the following schedule:

16,667 common shares shall vest as of the date of Grant (July 24, 2015);
16,667 common shares shall vest on the one year anniversary of the date of Grant (July 24, 2016); and,
16,666 common shares shall vest on the two year anniversary of the date of Grant (July 24, 2017).

The issuance of the stock award was approved by the Board of Directors of the Company.
 
Exemption from Registration. The shares of Common Stock referenced herein to be issued to Ms. Bountri will be issued in reliance upon the exemption from securities registration afforded by the provisions of Regulation S of the Securities Act of 1933, as amended, (“Securities Act”), as promulgated by the U.S. Securities and Exchange Commission under the Securities Act. Our reliance upon the exemption under Rule 903 of Regulation S of the Securities Act was based on the fact that the sales of the securities were completed in an "offshore transaction", as defined in Rule 902(h) of Regulation S. We did not engage in any directed selling efforts, as defined in Regulation S, in the United States in connection with the sale of the securities. The investor was not a US person, as defined in Regulation S, and was not acquiring the securities for the account or benefit of a US person.

A copy of the Grant Notice is filed as Exhibit 10.1 to this Current Report on Form 8-K.

SECTION 9   FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K:
 
Exhibit no.    Description  
10.1
 
 
Grant notice for stock award issued July 24, 2015
Filed herewith

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
HCi Viocare
   
Dated: July 29, 2015
By:
/s/ Sotirios Leontaritis
 
 Name:
Sotirios Leontaritis
 
 Title:
President, Treasurer, CEO, and Director

 

 
2